Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STS gene causes X-linked ichthyosis, even in rare female cases.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Dutasteride 0.5 mg daily improves hair growth safely in men with hair loss.

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

Patients with afro-textured hair often feel misunderstood by dermatologists regarding hair loss.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

The study created a 27-item measure to assess the impact of skin diseases.

Later line chemotherapy causes severe side effects, impacting quality of life, but patients continue treatment to extend life and stay connected with loved ones.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

New tools were created to help lupus patients report their symptoms and impacts more accurately.

Condensed nanofat with fat grafts effectively improves atrophic facial scars.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

The criteria help doctors diagnose and treat alopecia areata more effectively.

Middle-aged patients, those in the Northeast, with comprehensive insurance, extensive hair loss, or additional health issues, and young or older females face higher alopecia areata medical costs.

Patients with alopecia areata face treatment barriers due to lack of reimbursement and need more support and information.

Disease-specific tools better assess alopecia areata's impact on quality of life.

Patients with androgenetic alopecia have thinner subcutaneous fat layers in their frontal scalp compared to healthy individuals.

Patients need better counseling and resources for managing chemotherapy-induced hair loss.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

The cream effectively treats scalp psoriasis, improving symptoms and quality of life, with high patient satisfaction.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

The document concludes that hair transplant clinics should focus on effective marketing, online presence, and quality patient care, while the industry should promote high standards and education through organizations like FUE Europe.

More people are using online platforms for hair loss treatment due to convenience and privacy.

Patients reduced searches for dermatology issues during COVID-19, indicating a need for better telehealth services.

Hair regrowth in Alopecia Areata patients leads to increased satisfaction and reduced stress.

Dermatologists greatly affect inpatient diagnosis and treatment of skin conditions, especially in spotting infections in patients with weakened immune systems.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.